BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• 

  Business

  AbbVie Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc.’s Blood Cancer Drug; Deal Could Be Worth $805 Million

  September 3, 2014

   · 

  2 min read
• Can-Fite BioPharma To Present At Rodman & Renshaw Global Investment Conference In New York City On September 9, 2014

  September 3, 2014

   · 

  3 min read
• Drug Development

  Daiichi Sankyo Company, Limited Release: Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

  September 3, 2014

   · 

  11 min read
• Bio NC

  BioDelivery Sciences International To Ring The NASDAQ Stock Market Opening Bell

  September 3, 2014

   · 

  7 min read
• Policy

  Halozyme Therapeutics, Inc.'s PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation

  September 3, 2014

   · 

  3 min read
• Pharm Country

  Nephros Inc. Completes Bridge Financing

  September 3, 2014

   · 

  7 min read
• Pharm Country

  ContraVir To Present At Two Upcoming Investor Conferences

  September 3, 2014

   · 

  3 min read
• Biotech Beach

  Volcano Corporation Presentation At Morgan Stanley Conference To Be Webcast

  September 3, 2014

   · 

  1 min read
• BioCapital

  Synthetic Biologics, Inc. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City

  September 3, 2014

   · 

  2 min read
• Biotech Bay

  Sangamo BioSciences, Inc. Announces Presentation At The 2014 Morgan Stanley Global Healthcare Conference

  September 3, 2014

   · 

  1 min read